Pomerantz LLP has been appointed lead counsel in a suit asserting insolvent drugmaker Mallinckrodt PLC tricked investors into thinking it had recovered from bankruptcy and would make a $200 million payment...
Want to continue reading?
Take a 7 Day FREE Trial
Unlock these benefits today when you sign-up for a FREE 7-day trial:
- Gain a competitive edge with exclusive data visualization tools to tailor to your practice
- Stay informed with daily newsletters and custom alerts across 14+ coverage areas relevant to you
- Streamline your business of law needs with integrated news and research in a single destination
Already have an account? Sign In Now
